Olimab 60 Mg Injection

Product Description

Olimab 60 mg injection contains omalizumab as its active ingredient, which is a monoclonal antibody used to treat certain allergic conditions, particularly moderate to severe asthma and chronic urticaria (hives) that are not well controlled with other medications. Omalizumab works by binding to immunoglobulin E (IgE), an antibody involved in allergic reactions, thereby preventing it from interacting with its receptors on immune cells. This helps to reduce inflammation and allergic responses in the body.

For asthma, Olimab is typically prescribed to patients whose asthma is not controlled with inhaled corticosteroids or other asthma medications. It can help reduce the frequency of asthma attacks, improve lung function, and reduce the need for oral steroids. In chronic urticaria, it helps reduce the severity and frequency of hives and itching in patients who do not respond to antihistamine therapy.

The injection is usually administered once every 2 or 4 weeks, depending on the specific condition being treated and the patient's response to the medication. It is given as a subcutaneous (under the skin) injection by a healthcare provider, and the exact dose is determined based on factors such as the patient™s weight and the severity of the condition being treated.

Like any medication, Olimab 60 mg injection may cause side effects. Common side effects include reactions at the injection site (such as redness, swelling, or pain), headache, and upper respiratory infections. Less commonly, it may cause more serious side effects such as an allergic reaction, which can include symptoms like difficulty breathing, swelling of the face or throat, or rash. It is important to contact a healthcare provider immediately if any of these symptoms occur.

Patients should inform their doctor about any pre-existing conditions, such as a history of anaphylaxis, before starting treatment with Olimab. It is also important to continue using other prescribed asthma medications or allergy treatments unless otherwise directed by the healthcare provider.